Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer

NCT00052585 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Adenocarcinoma of the Colon
Adenocarcinoma of the Rectum
Mucinous Adenocarcinoma of the Colon
Mucinous Adenocarcinoma of the Rectum
Recurrent Colon Cancer
Recurrent Rectal Cancer
Signet Ring Adenocarcinoma of the Colon
Signet Ring Adenocarcinoma of the Rectum
Stage IV Colon Cancer
Stage IV Rectal Cancer

Interventions

DRUG: irinotecan hydrochloride
DRUG: gefitinib
DRUG: leucovorin calcium
DRUG: fluorouracil

Sponsor

National Cancer Institute (NCI)